Human remains from the early Bronze Age indicate a life expectancy of 24 years, yet this number tells a story far more complex than a simple death sentence for the ancient world. This statistic, known as life expectancy at birth, is heavily skewed by the high mortality rates of infants and young children. In a society where half of all children might die before reaching adolescence, the average lifespan appears tragically short, but it does not mean that most people died at the age of 24. Those who survived the dangers of early childhood often lived into their 50s or 60s, and for the lucky few, well beyond. The true measure of survival in ancient times is found not in the average age at death, but in the life expectancy at age 15, which could reach 39 years for hunter-gatherer populations. This distinction reveals that the ancient world was not a place where everyone died young, but rather a place where the odds of surviving the first few years were stacked heavily against the vulnerable. The concept of life expectancy is an arithmetic mean, a statistical average that can be grossly misinterpreted if one fails to account for the distribution of deaths across the lifespan. A population with a life expectancy of 40 would have relatively few people dying at exactly 40; instead, the deaths would be concentrated at the very beginning of life or in the later years of those who survived the initial gauntlet. This statistical nuance is crucial for understanding the history of human survival and the dramatic shifts that have occurred over millennia.
The Longevity Paradox
The longest verified lifespan for any human is that of Jeanne Calment, a French woman who lived to 122 years and 164 days, passing away on the 4th of August 1997. Her life span, stretching from the 21st of February 1875 to her death, represents the upper boundary of human existence, a maximum life span that has remained remarkably constant despite modern medical advances. While the average life expectancy at birth has climbed from 24 years in the Bronze Age to 73.3 years in 2019, the maximum potential for human life has not increased proportionally. Some theoretical studies suggest that genetic enhancements could allow humans to live for 245 years, yet the biological limit appears to hover around 125 years. The discrepancy between the rising average and the static maximum highlights the difference between life expectancy and maximum life span. Life expectancy is a measure of the average remaining years of life at a given age, while maximum life span is the age at death for the longest-lived individual of a species. This distinction is vital for understanding the history of aging and the persistent biological constraints that have governed human existence for thousands of years. The fact that the maximum life span has not increased significantly suggests that the dramatic rise in life expectancy is due to the reduction of early deaths rather than an extension of the biological clock itself. This paradox challenges the popular narrative that humans are living longer in every sense, revealing instead that we are simply surviving childhood and young adulthood with greater success than our ancestors.
During the 20th century, the average lifespan in the United States increased by more than 30 years, with 25 years of that gain attributed to advances in public health rather than medical treatments for the elderly. This dramatic shift began in the 19th century, when recorded deaths among children under the age of 5 years in London fell from 74.5% of recorded births in the period 1730 to 1749 to 31.8% in 1810 to 1829. The Industrial Revolution brought about a transformation in mortality rates, as improvements in sanitation, nutrition, and disease control began to take hold. Before this revolution, life expectancy in England was under 25 years in the early Colony of Virginia, and in 17th-century New England, about 40% of children died before reaching adulthood. The decline in infant mortality was the primary driver of the increase in life expectancy, as it removed the heavy statistical weight of early deaths that had previously dragged down the average. In the 1840s, English life expectancy at birth reached 41 years, climbing to 46 by the 1890s, though infant mortality remained at around 150 per thousand throughout this period. The public health measures credited with much of the recent increase in life expectancy include the reduction of infectious diseases, the improvement of water supplies, and the implementation of vaccination programs. These measures have allowed populations to survive the early years of life, thereby increasing the average age at death without necessarily extending the maximum potential of the human body. The story of life expectancy is, in large part, the story of how humanity learned to protect its youngest members from the ravages of disease and poverty.
The Gender Divide
Modern female human life expectancy is greater than that of males, despite females having higher morbidity rates, a phenomenon known as the health survival paradox. In the United States, white Americans in 2010 are expected to live until age 78.9, while black Americans only until age 75.1, a gap of 3.8 years that represents the lowest difference since 1975. The difference in life expectancy between men and women in the United States dropped from 7.8 years in 1979 to 5.3 years in 2005, with women expected to live to age 80.1 in 2005. This disparity is attributed to a combination of biological and environmental factors, including the fact that men have historically consumed more tobacco, alcohol, and drugs than women in most societies. Men are also more likely to die from injuries, whether unintentional such as occupational accidents or car wrecks, or intentional such as suicide. The mortality rates for females in child-bearing age groups were historically higher than for males at the same age, but this has changed as medical care has improved. In developed countries, starting around 1880, death rates decreased faster among women, leading to differences in mortality rates between males and females. Before 1880, death rates were the same, but the decline in infectious diseases allowed the biological differences in mortality to become more apparent. The unguarded X hypothesis suggests that the Y chromosome in males cannot protect an individual from harmful genes expressed on the X chromosome, while a duplicate X chromosome in females can ensure harmful genes are not expressed. This biological difference, combined with environmental and behavioral risk factors, has resulted in a consistent pattern of female longevity across the globe.
The Inequality Gap
In Glasgow, the disparity in life expectancy is amongst the highest in the world, with life expectancy for males in the heavily deprived Calton area standing at 54, which is 28 years less than in the affluent area of Lenzie. This stark contrast illustrates how economic circumstances and social inequality can have a profound impact on the length of life. In the United Kingdom, life expectancy in the wealthiest and richest areas is several years higher than in the poorest areas, reflecting factors such as diet, lifestyle, and access to medical care. The relationship between economic inequality and life expectancy is strong, with a correlation coefficient of negative 0.907 for the top 21 industrialized countries. In the United States, the gap between low-income and high-income neighborhoods in cities like Cincinnati touches 20 years, highlighting the severe consequences of poverty on health outcomes. The life expectancy of people with mental disorders is reduced by 10 to 25 years, and those with diabetes have a life expectancy reduced by roughly 10 to 20 years. The study of the Chinese emperors from the first Qin Dynasty to the last Qing Dynasty found an average life expectancy of 41.3 years, which is much lower than that of Buddhist monks at 66.9 years and traditional Chinese doctors at 75.1 years. This suggests that wealth and power do not necessarily translate to longevity, and that factors such as stress, diet, and access to quality medical care play a more significant role. The economic circumstances that affect life expectancy are deeply rooted in social structures, and addressing these disparities requires a comprehensive approach to public health and social policy.
The Genetic Mystery
The heritability of lifespan is estimated to be less than 10%, meaning the majority of variation in lifespan is attributable to differences in environment rather than genetic variation. However, researchers have identified regions of the genome which can influence the length of life and the number of years lived in good health. A genome-wide association study of 1 million lifespans found 12 genetic loci which influenced lifespan by modifying susceptibility to cardiovascular and smoking-related disease. The locus with the largest effect is APOE, and carriers of the APOE ε4 allele live approximately one year less than average, mainly due to increased risk of Alzheimer's disease. In July 2020, scientists identified 10 genomic loci with consistent effects across multiple lifespan-related traits, including healthspan, lifespan, and longevity. The genes affected by variation in these loci highlighted haem metabolism as a promising candidate for further research within the field. This study suggests that high levels of iron in the blood likely reduce, and genes involved in metabolising iron likely increase healthy years of life in humans. The ability of skin fibroblasts to perform DNA repair after UV irradiation was measured in shrew, mouse, rat, hamster, cow, elephant and human, and it was found that DNA repair capability increased systematically with species life span. Since this original study in 1974, at least 14 additional studies were performed on mammals to test this correlation, suggesting that DNA repair capability contributes to life expectancy. The genetic factors that influence lifespan are complex and multifaceted, and while they play a role, the environment remains the primary determinant of how long a person lives.
The Future of Aging
In developed countries, the number of centenarians is increasing at approximately 5.5% per year, which doubles the centenarian population every 13 years, pushing it from some 455,000 in 2009 to 4.1 million in 2050. Japan has the highest ratio of centenarians, with 347 for every 1 million inhabitants in September 2010, and Shimane Prefecture had an estimated 743 centenarians per million inhabitants. The long-standing quest for longer life led in the 2010s to a focus on increasing healthy life expectancy, also known as a person's healthspan. Besides the benefits of keeping people healthier longer, a goal is to reduce health-care expenses on the many diseases associated with cellular senescence. Approaches being explored include fasting, exercise, and senolytic drugs. The life expectancy statistic is usually based on past mortality experience and assumes that the same age-specific mortality rates will continue, but such figures need to be adjusted for temporal trends before calculating how long a currently living individual of a particular age is expected to live. The Lee-Carter model is one of the most important approaches in forecasting age-specific death rates, using singular value decomposition to reduce dimensionality and forecast mortality trends. As of 2025, some AI apps claim to be able to predict individual life expectancy and death dates through a combination of population statistics and individual factors. The future of aging is a complex interplay of genetic, environmental, and technological factors, and the quest to extend life continues to be a major focus of scientific research and public policy.